MESCIA, FEDERICA
 Distribuzione geografica
Continente #
AS - Asia 1.413
NA - Nord America 1.287
EU - Europa 631
SA - Sud America 259
AF - Africa 30
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.624
Nazione #
US - Stati Uniti d'America 1.245
SG - Singapore 584
CN - Cina 271
HK - Hong Kong 243
BR - Brasile 214
IT - Italia 158
DE - Germania 103
VN - Vietnam 80
FI - Finlandia 72
GB - Regno Unito 57
BD - Bangladesh 56
FR - Francia 55
TR - Turchia 52
RU - Federazione Russa 45
IN - India 34
IE - Irlanda 31
CA - Canada 22
AR - Argentina 19
JP - Giappone 18
NL - Olanda 18
UA - Ucraina 18
ID - Indonesia 14
MX - Messico 14
IQ - Iraq 13
AT - Austria 12
PL - Polonia 12
ES - Italia 11
SA - Arabia Saudita 10
ZA - Sudafrica 9
CO - Colombia 8
LT - Lituania 8
MA - Marocco 7
SE - Svezia 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
VE - Venezuela 5
IL - Israele 4
JO - Giordania 4
LV - Lettonia 4
PH - Filippine 4
PS - Palestinian Territory 4
BY - Bielorussia 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
GY - Guiana 3
KZ - Kazakistan 3
NP - Nepal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
KE - Kenya 2
LU - Lussemburgo 2
LY - Libia 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KI - Kiribati 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
Totale 3.624
Città #
Singapore 292
Hong Kong 243
Ashburn 174
San Jose 174
The Dalles 74
Beijing 69
Council Bluffs 61
Helsinki 56
Los Angeles 56
Chandler 53
Lauterbourg 42
Istanbul 41
New York 30
Dublin 29
Buffalo 22
Frankfurt am Main 21
Moscow 21
Hanoi 20
Ho Chi Minh City 19
Munich 19
Santa Clara 19
Chicago 18
Nuremberg 18
Romola 18
São Paulo 18
Dallas 17
Orem 17
London 15
Brescia 14
Redondo Beach 14
Shanghai 14
Jakarta 13
Tokyo 13
Chennai 12
Denver 11
Amsterdam 10
Atlanta 10
Brooklyn 10
Turku 10
Wilmington 10
Bologna 9
Düsseldorf 9
San Francisco 9
Cambridge 8
Florence 8
Mexico City 8
Milan 8
Princeton 8
Rome 8
Rovito 8
Ankara 7
Boston 7
Montreal 7
Seattle 7
Woodbridge 7
Belo Horizonte 6
Dhaka 6
Fairfield 6
Houston 6
Kyiv 6
Lappeenranta 6
Toronto 6
Brno 5
City of London 5
Elk Grove Village 5
Haiphong 5
Phoenix 5
Poplar 5
Porto Alegre 5
Rio de Janeiro 5
Stockholm 5
Tianjin 5
Vienna 5
Warsaw 5
Amman 4
Bengaluru 4
Gonars 4
Guangzhou 4
Jacksonville 4
Jeddah 4
Johannesburg 4
Lowicz 4
Manaus 4
Mumbai 4
Newark 4
Ninh Bình 4
Riga 4
Baghdad 3
Barcelona 3
Bergamo 3
Changsha 3
Charlotte 3
Da Nang 3
Des Moines 3
Georgetown 3
Hanover 3
Kansas City 3
Kilburn 3
Las Vegas 3
Manchester 3
Totale 2.108
Nome #
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 152
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 136
Sustained post-rituximab B cell depletion is common in ANCA-associated Vasculitis and affected by sex and renal function 118
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity 109
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype 102
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving 96
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination 93
Analysis of the B cell receptor repertoire in six immune-mediated diseases 92
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion 90
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 87
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 87
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 85
Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients 84
Effective control of sars-cov-2 transmission between healthcare workers during a period of diminished community prevalence of covid-19 84
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 83
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant 81
Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis 81
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19 79
Eosinophilic granulomatosis with polyangiitis present and future 79
A thermostable, closed SARS-CoV-2 spike protein trimer 78
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 77
SARS-CoV-2 evolution during treatment of chronic infection 77
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease 76
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection 74
Clinical Significance of the Cystic Phenotype in Alport Syndrome 73
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study 72
Treatment goals in ANCA-associated vasculitis: defining success in a new era 68
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 67
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups 67
The impact of hypoxia on B cells in COVID-19 67
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia 65
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission 63
Prevention and Therapeutic Management of Bleeding in Dialysis Patients 60
Single-cell multi-omics analysis of the immune response in COVID-19 60
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 58
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies 56
STEC-HUS, atypical HUS and TTP are all diseases of complement activation 56
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report 55
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity 55
Kidney transplantation from a donor with acute kidney injury: An unexpected outcome 54
Proinflammatory cytokines driving cardiotoxicity in COVID-19 50
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 50
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study 45
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 45
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 44
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab 41
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID 39
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity 36
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 32
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience 27
#6036 CYSTIC KIDNEY PHENOTYPE IS A FREQUENT, AGE- AND EGFR- DEPENDENT FINDING IN ALPORT SYNDROME 17
Kidney Outcomes in ANCA-Glomerulonephritis According to Induction Immunosuppression and Histopathology 13
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centres 7
Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN 6
Response to the Letter to the Editor entitled “Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings” 6
Totale 3.654
Categoria #
all - tutte 22.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 1 2 0 0 0 1 0 0 6 3 3 7
2022/2023174 7 0 5 18 5 59 0 21 37 2 10 10
2023/2024345 15 16 8 40 13 11 10 49 100 7 14 62
2024/2025942 4 10 28 109 73 90 83 87 102 97 170 89
2025/20262.120 198 260 166 204 180 175 330 88 143 216 138 22
Totale 3.654